BioIntelligence Technologies is a technology company.
BioIntelligence Technologies has raised $5.0M across 2 funding rounds.
BioIntelligence Technologies has raised $5.0M in total across 2 funding rounds.
BioIntelligence Technologies has raised $5.0M in total across 2 funding rounds.
BioIntelligence Technologies's investors include 2048 Ventures, Innospark Ventures, Pioneer Fund, Metanoia.
BioIntelligence Technologies is a Canadian biotechnology company founded in 2014 that develops and commercializes innovative instruments and software for real-time monitoring, analysis, and optimization of bioprocesses in biomanufacturing[1][2][3][4]. Their core products, BiOptic+ (an inline spectrometer for snapshot measurements of bioprocess variables) and BioAnalyst (software for real-time data integration and analytics), enable clients to track products, nutrients, metabolic intermediates, detect deviations, reduce contaminations, and boost productivity in fermentation and cell culture processes[1][3][4][5]. Serving the biomanufacturing sector—including bioethanol, food, probiotics, industrial compounds, biofertilizers, polymers, and cosmetics—the company addresses inefficiencies in bioprocess development, with $5M in total funding, ~$6.1M revenue, and <25 employees based in Sherbrooke, Quebec[1][2].
BioIntelligence Technologies was founded in 2014 by Joel Sirois, P.Eng., Ph.D., an accomplished biotechnology leader with over 20 years of experience, including co-founding Avance Pharma in 1997 for natural-origin pharmaceutical compounds and directing bioengineering at Université de Sherbrooke from 2006, where he developed real-time bioprocess optimization platforms[4]. The idea emerged from Sirois's personal goal to accelerate access to new medications and greener chemicals, combining business intelligence with scientific intelligence for real-time bioprocess profitability maximization after 15+ years of innovation starting around 2007[4][5]. Early traction built on proven technology refined for industrial conditions, leading to deployments at production sites and recent participation in Québec Tech's accelerator for US/Europe sales growth[2].
BioIntelligence rides the intelligent biomanufacturing trend, leveraging real-time data analytics amid rising demand for efficient, sustainable production of biochemicals, biofuels, and biologics in a $500B+ global biopharma market[1][2][5]. Timing aligns with post-pandemic supply chain pressures and green chemistry pushes, where process deviations cost billions; their tools reduce variability, supporting scalability for cell/gene therapies and fermented products[1][4]. By enabling proactive control in fermentations, they influence the ecosystem through partnerships (e.g., Québec Tech) and tech transfer from academia, accelerating bioprocess R&D for startups and incumbents in Canada’s biotech hub[2][4].
BioIntelligence is poised for accelerated growth via US/Europe expansion, new clients, and partnerships, building on $5M funding and revenue momentum toward support programs like Investissement Québec[1][2]. Trends like AI-driven bioprocessing and sustainability will amplify their edge, potentially evolving them into a platform leader as real-time analytics become standard. Their influence may grow by powering next-gen biofactories, tying back to Sirois's vision of greener, faster biomanufacturing for global impact[4][5].
BioIntelligence Technologies has raised $5.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2024 | $4.0M Seed | 2048 Ventures, Innospark Ventures, Pioneer Fund | |
| Jan 1, 2016 | $1.0M Seed | Metanoia |